138 related articles for article (PubMed ID: 37438087)
21. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
[TBL] [Abstract][Full Text] [Related]
22. Effect of Vitamin D Status on Von Willebrand Factor and ADAMTS13 in Diabetic Patients on Chronic Hemodialysis.
Cohen-Hagai K; Rashid G; Einbinder Y; Ohana M; Benchetrit S; Zitman-Gal T
Ann Lab Med; 2017 Mar; 37(2):155-158. PubMed ID: 28029003
[TBL] [Abstract][Full Text] [Related]
23. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
24. Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.
Green D; Tian L; Greenland P; Liu K; Kibbe M; Tracy R; Shah S; Wilkins JT; Huffman MD; Liao Y; Lloyd Jones D; McDermott MM
Clin Appl Thromb Hemost; 2017 Oct; 23(7):807-813. PubMed ID: 27317583
[TBL] [Abstract][Full Text] [Related]
25. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
[TBL] [Abstract][Full Text] [Related]
26. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
[TBL] [Abstract][Full Text] [Related]
27. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
28. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
29. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
[TBL] [Abstract][Full Text] [Related]
30. von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.
Murphy SJX; Lim ST; Hickey F; Kinsella JA; Smith DR; Tierney S; Egan B; Feeley TM; Murphy SM; Collins DR; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; O'Donnell JS; O'Sullivan JM; Hamilton G; McCabe DJH
Thromb Haemost; 2021 Jan; 121(1):86-97. PubMed ID: 32932544
[TBL] [Abstract][Full Text] [Related]
31. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
[TBL] [Abstract][Full Text] [Related]
32. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
[TBL] [Abstract][Full Text] [Related]
33. Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.
Wang A; Liu F; Dong N; Ma Z; Zhang J; Su J; Zhao Y; Ruan C
Thromb Res; 2010 Oct; 126(4):e260-5. PubMed ID: 20705333
[TBL] [Abstract][Full Text] [Related]
34. Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population.
Wang Z; Dou M; Du X; Ma L; Sun P; Cao H; Ye S; Jiang P; Liu F; Lin F; Zhang R; Li C
PeerJ; 2017; 5():e3156. PubMed ID: 28382235
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.
Xu X; Feng Y; Jia Y; Zhang X; Li L; Bai X; Jiao L
Thromb Res; 2022 Oct; 218():83-98. PubMed ID: 36027630
[TBL] [Abstract][Full Text] [Related]
36. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy.
Groeneveld DJ; Alkozai EM; Adelmeijer J; Porte RJ; Lisman T
Br J Surg; 2016 May; 103(6):735-743. PubMed ID: 27005894
[TBL] [Abstract][Full Text] [Related]
37. Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy.
Kobayashi S; Yokoyama Y; Matsushita T; Kainuma M; Ebata T; Igami T; Sugawara G; Takahashi Y; Nagino M
Arch Surg; 2012 Oct; 147(10):909-17. PubMed ID: 23117828
[TBL] [Abstract][Full Text] [Related]
38. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
[TBL] [Abstract][Full Text] [Related]
39. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.
Strauss T; Elisha N; Ravid B; Rosenberg N; Lubetsky A; Levy-Mendelovich S; Morag I; Nowak Göttl U; Kenet G
Blood Cells Mol Dis; 2017 Sep; 67():14-17. PubMed ID: 28087247
[TBL] [Abstract][Full Text] [Related]
40. ADAMTS13 regulation of VWF multimer distribution in severe COVID-19.
Ward SE; Fogarty H; Karampini E; Lavin M; Schneppenheim S; Dittmer R; Morrin H; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Mallon PW; Curley GF; Baker RI; Budde U; O'Sullivan JM; O'Donnell JS;
J Thromb Haemost; 2021 Aug; 19(8):1914-1921. PubMed ID: 34053187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
